全球心臟衰竭檢測設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計心臟衰竭檢測設備市場將從 2025 年的 152.5 億美元成長到 2034 年的 263.4 億美元，2026 年至 2034 年的複合年成長率為 6.26%。

隨著全球心血管疾病發生率的上升，全球心臟衰竭檢測設備市場正在迅速擴張。人口老化、久坐的生活方式以及高血壓和糖尿病盛行率的不斷攀升，都是導致心臟衰竭病例增加的原因。早期檢測設備有助於監測心臟功能並預防嚴重併發症。人們對預防性醫療保健和遠端監測解決方案的日益重視，正在推動市場成長。

穿戴式心臟監視器、植入式感測器和基於人工智慧的診斷工具等技術進步是主要驅動力。遠端醫療平台與心臟監護設備的整合實現了即時數據共用和及時的臨床干預。政府推廣心血管健康篩檢計畫的措施進一步促進了這些技術的普及。此外，醫療機構也正在投資先進的診斷設備，以改善病患的治療效果。

由於預測分析和機器學習演算法在早期風險評估方面的發展，未來前景十分樂觀。新興市場醫療基礎設施的擴張將帶來額外的需求。小型化和無線監測系統的持續創新將提高患者的舒適度和依從性。隨著醫療系統向疾病預防管理轉型，心臟衰竭檢測市場預計將迎來強勁成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球心臟衰竭檢測設備市場：依產品類型分類

• 市場分析、洞察與預測
• 系統（多普勒血流動力學監測儀、植入式血流動力學監測儀（IHM）、植入式肺動脈監測裝置、胸內電阻監測儀、通用心臟衰竭監測儀）
• 資料管理軟體

第5章 全球心臟衰竭檢測設備市場：依技術分類

• 市場分析、洞察與預測
• 有線
• 無線的

第6章：全球心臟衰竭檢測設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 門診手術中心
• 診斷影像中心
• 醫院

第7章 全球心臟衰竭偵測設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories Inc
  • Boston Scientific Corporation
  • Medtronic Plc
  • General Electric（GE HealthCare）
  • Koninklijke Philips NV
  • Avertix Medical Inc
  • Endotronix Inc
  • Uscom Ltd
  • Biotronik SE & Co. KG
  • IRhythm Technologies Inc

The Heart Failure Detection Devices Market size is expected to reach USD 26.34 Billion in 2034 from USD 15.25 Billion (2025) growing at a CAGR of 6.26% during 2026-2034.

The Global Heart Failure Detection Devices Market is expanding rapidly due to the increasing prevalence of cardiovascular diseases worldwide. Aging populations, sedentary lifestyles, and rising rates of hypertension and diabetes are contributing to higher heart failure cases. Early detection devices help monitor cardiac function and prevent severe complications. Growing awareness about preventive healthcare and remote monitoring solutions is driving market growth.

Technological advancements such as wearable cardiac monitors, implantable sensors, and AI-based diagnostic tools are key drivers. The integration of telehealth platforms with heart monitoring devices enables real-time data sharing and timely clinical intervention. Government initiatives promoting cardiovascular health screening programs are further supporting adoption. Additionally, healthcare providers are investing in advanced diagnostic equipment to improve patient outcomes.

Future prospects appear promising with the development of predictive analytics and machine learning algorithms for early risk assessment. Expanding healthcare infrastructure in emerging economies will create additional demand. Continuous innovation in miniaturized and wireless monitoring systems will enhance patient comfort and compliance. As healthcare systems shift toward proactive disease management, the heart failure detection devices market is expected to witness robust growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Systems (Doppler Hemodynamics Monitors, Implantable Hemodynamic Monitors (IHM), Implantable Pulmonary Artery Monitoring Devices, Intrathoracic Impedance Monitors, General HF Monitors)
• Data Management Software

By Technology

• Wired
• Wireless

By End User

• Ambulatory Surgical Centers
• Diagnostic Imaging Centers
• Hospitals

COMPANIES PROFILED

• Abbott Laboratories Inc, Boston Scientific Corporation, Medtronic Plc, General Electric GE HealthCare, Koninklijke Philips NV, Avertix Medical Inc, Endotronix Inc, Uscom Ltd, Biotronik SE Co KG, iRhythm Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEART FAILURE DETECTION DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Systems (Doppler Hemodynamics Monitors, Implantable Hemodynamic Monitors (IHM), Implantable Pulmonary Artery Monitoring Devices, Intrathoracic Impedance Monitors, General HF Monitors) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Data Management Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEART FAILURE DETECTION DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Wired Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Wireless Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEART FAILURE DETECTION DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEART FAILURE DETECTION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Technology
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Technology
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Technology
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Technology
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Technology
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEART FAILURE DETECTION DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories Inc
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Medtronic Plc
  • 9.2.4 General Electric (GE HealthCare)
  • 9.2.5 Koninklijke Philips N.V
  • 9.2.6 Avertix Medical Inc
  • 9.2.7 Endotronix Inc
  • 9.2.8 Uscom Ltd
  • 9.2.9 Biotronik SE & Co. KG
  • 9.2.10 IRhythm Technologies Inc